|
Volume 271, Number 34,
Issue of August 23, 1996
pp. 20705-20712
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Normal T Cells Express Two T Cell Antigen Receptor Populations,
One of Which Is Linked to the Cytoskeleton via Chain and Displays a
Unique Activation-dependent Phosphorylation Pattern*
(Received for publication, March 5, 1996)
Steve
Caplan
and
Michal
Baniyash
From The Lautenberg Center for General and Tumor Immunology, Hebrew
University-Hadassah Medical School, Jerusalem 91120, Israel
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
The TCR couples antigen recognition and the
transmission of activation signals. We report the expression of two TCR
populations on the surface of T lymphocytes, one of which is linked to
the cytoskeleton via the chain. We also demonstrate that assembly
of the CD3 subunits with cytoskeleton-associated is necessary for
their maximal localization to the cytoskeleton. The potential
significance of these two receptor forms is underscored by differences
observed in non-activated T cells; while detergent-soluble
phosphorylated appears as a 21-kDa protein, phosphorylated
cytoskeleton-associated appears as a 16-kDa form. This dichotomous
phosphorylation pattern is rigidly maintained following activation,
although each of the receptor populations undergoes different
activation-dependent modifications: 1) levels of soluble
phosphorylated 21-kDa are enhanced, while phosphorylated 16-kDa
cytoskeleton-associated exhibits little change; 2) soluble
non-phosphorylated 16-kDa translocates to the cytoskeleton; 3)
activation-dependent ubiquitinated forms localize
to both fractions, albeit with different kinetics. We also show that
the protein tyrosine kinase Lck undergoes
activation-dependent modifications and translocates to the
cytoskeleton. The phosphorylation profiles of the dichotomous TCR
populations in both non-activated and activated lymphocytes suggest
that each population could regulate distinct cellular functions,
possibly by select intermolecular associations.
INTRODUCTION
The TCR1 is a multisubunit complex
composed of the clonotypic / disulfide-linked heterodimer and the
invariant disulfide-linked / and/or / dimers (1). While the
/ heterodimers are involved in antigen-major histocompatibility
complex recognition and binding, the invariant chains couple antigen
recognition to various intracellular signal transduction pathways (1,
2). Cumulative evidence from various studies indicates that of the
invariant chains, plays a key role in the transmission of
activation signals in the process of T cell stimulation (3, 4, 5, 6).
None of the TCR subunits possess intrinsic kinase activity, therefore
association of the invariant subunits with various intracellular
molecules appears to be crucial for mediating the signaling process.
Little is known about such associations in non-activated T cells. Thus
far, only the protein tyrosine kinase Fyn has been found to maintain a
constitutive association with the non-phosphorylated chain in
non-activated T cells (7, 8). However, recent reports (9, 10) have
shown that freshly isolated, non-activated thymocytes and lymph node T
cells express a basal level of tyrosine-phosphorylated chain, to
which the ZAP-70 protein tyrosine kinase is constitutively associated
in a phosphorylation dependent manner. Following TCR cross-ligation,
Src family tyrosine kinases Fyn and Lck are activated, promoting
augmented tyrosine phosphorylation of the and subunits and
enhanced recruitment of ZAP-70. The latter is then phosphorylated by
the Src family tyrosine kinases, culminating in its activation.
In vitro studies have shown that the phosphorylated chain can also interact with adapter proteins such as Shc (11) and/or
Grb2 (12), resulting in coupling of the TCR to the Ras signaling
pathway. It remains to be determined whether additional intracellular
molecules interact with the TCR invariant subunits and what role(s)
such interactions play, particularly in non-activated T cells.
We have previously shown that 10-40% of the TCR chains are linked
to the cytoskeleton in non-activated T cells, and that this linkage is
dependent upon the integrity of the actin microfilament system (13). A
recent study by Rozdzial et al. (14) supports our findings
and shows that chain can be co-immunoprecipitated with actin. The
potential significance of the association of various cell surface
receptors with the cytoskeleton is reflected by a number of recent
studies (reviewed in Ref. 15). Such associations have been observed for
the following cell surface-expressed molecules: epidermal growth factor
receptors (16, 17), integrin receptors (18), CD2 (19), the tyrosine
phosphatase CD45 (20), the B cell antigen receptor (21, 22, 23, 24), and the
high affinity receptor for immunoglobulin E (Fc R1) (25, 26, 27).
However, the physiologic relevance of most of these interactions is at
present unclear.
In the current study we extend our understanding of the interactions
between chain, the CD3 , , and subunits and the
cytoskeletal matrix in non-activated T cells. We demonstrate that
cytoskeleton-associated (cska- ) chain is assembled within a
complex containing the TCR subunits in normal mouse lymphocytes.
Furthermore, we have shown in this study that the localization of CD3
to the Triton-insoluble fraction is largely dependent on the presence
of the cska- chain. Our results suggest that there are two cell
surface-expressed TCR populations: Triton-soluble receptors and
Triton-insoluble receptors, of which only the latter are linked to the
cytoskeleton via the TCR chain. We demonstrate that in
non-activated mouse lymphocytes, the Triton-insoluble cska- chain
differs from its Triton-soluble counterpart in its phosphorylation
state and possibly also in its conformation. While these differentially
phosphorylated forms are maintained in their respective fractions
subsequent to TCR-mediated triggering, we have established that various
ubiquitinated phosphorylated forms are common to both soluble and
cytoskeletal fractions, albeit with different kinetics. Finally, we
provide data showing that Lck, a key protein tyrosine kinase involved
in TCR-mediated signaling, displays a cytoskeletal localization which
is dependent on the state of cellular activation. These results suggest
that the cska- form could play a unique role in mediating signal
transduction events initiated by receptor cross-ligation and
transmitted via the cytoskeleton. The outcome of cytoskeletal
involvement could result either in T cell activation, or alternatively
serve to negatively regulate signals transmitted via the TCR by
inducing anergy and/or cell death. The -cytoskeleton linkage may
also affect receptor stability, and events such as internalization
and/or recycling, processes which occur in both non-activated and
activated T cells.
EXPERIMENTAL PROCEDURES
Animals
BALB/c female mice were bred in our SPF
facility.
Cells and Antibodies
Thymocytes were isolated from mice
aged 4 weeks and splenocytes were derived from mice aged 12-16 weeks.
The antigen-specific T-cell hybridoma 2B4 and -deficient T-cell
hybridomas 5.8 were grown as described (28). The 145-2C11 (2C11)
hamster monoclonal antibody is directed against the murine CD3 chain
(29). Anti-CD3- and anti- polyclonal antibodies were generated in
rabbits as described (30, 31). Anti-CD3 and anti-CD3 polyclonal
antibodies were generated in rabbits immunized with denatured protein
eluted from SDS-PAGE. The monoclonal anti-phosphotyrosine antibody 4G10
was obtained from Upstate Biotechnology (Lake Placid, NY).
Immunoprecipitations were done using antibodies bound to protein
A-Sepharose beads (Pharmacia).
Cell-surface Labeling
Cells were radiolabeled with
Na125I by lactoperoxidase as described previously (13). For
biotinylation, cells (1 × 108) were resuspended in a
buffer (pH 8.8) containing 10 mM sodium borate, 150 mM NaCl, and 50 µg/ml
D-biotinyl- -amidocaproic acid
N-hydroxysuccinimide ester (biotin-ester) (Boehringer
Mannheim) for 45 min at 22 °C. The reaction was terminated by the
addition of 10 mM ammonium chloride and cells were washed 3 times at 4 °C with phosphate-buffered saline.
Chain Constructs and Transfection of -Deficient T
Cells
The full-length murine cDNA construct has been
previously described (32). The cDNA was inserted into the PCDLSR
expression vector that contains the simian virus 40 promoter (33). The
expression vector was provided by Stuart Frank (University of Alabama,
Birmingham). The Tac construct encodes for a fusion protein
composed of the extracellular domain of the IL-2 receptor chain,
the transmembrane and intracytoplasmic domains of chain (34) and
was provided by Francois Letourneur (Basel Institute for Immunology,
Switzerland). 5.8 cells (1 × 107) were suspended in 2 ml of RPMI containing 30 µg/ml DEAE-dextran and transfected with 10 µg of cDNA. Cells were then incubated at 37 °C for 45 min,
washed three times, incubated for a further 42 h and
harvested.
Activation of Mature Mouse Lymphocytes
To minimize the
level of basal activation, splenocytes were isolated and ``rested''
by incubation at 37 °C overnight in RPMI supplemented with 8% fetal
calf serum. These non-activated splenocytes were harvested, washed, and
incubated at 37 °C with continuous shaking for the indicated times
in the presence of 2C11 ascites (1:250). No additional cross-linking
antibodies were necessary since the splenocyte population amply
provided the natural antigen presenting cells. The activation was
terminated by cooling the cells to 4 °C and diluting the samples
with Hanks' balanced salt solution containing phosphatase inhibitors.
Cells were washed 3 times prior to lysis.
Cell Lysis and Separation of Detergent-soluble and -insoluble
Fractions
Cell pellets were lysed either as described previously
(13) or by using modified lysis buffer containing 0.5% Triton X-100,
50 mM MES (pH 6.9), 10 µg/ml both aprotonin and
leupeptin, 1 mM phenylmethylsulfonyl fluoride, 1.8 mg/ml
iodoacetamide and phosphatase inhibitors. Cell pellets were lysed for
15 min on ice with gentle mixing and centrifuged (15,000 rpm) for 10 min at 4 °C. The supernatant was designated as the soluble fraction,
and the insoluble pellet was washed for 3 min in the same lysis buffer
and centrifuged again under the same conditions. The washed pellet was
designated as the insoluble fraction. For analysis of the total
insoluble fraction, proteins were extracted by mechanical agitation and
incubated for 20 min at 95 °C in sample buffer containing 4% SDS.
For immunoprecipitations of proteins from the insoluble fraction,
Triton-insoluble pellets were suspended in 200 µl of buffer
containing 30 mM NaCl, 5 mM MgCl2,
protease inhibitors, 20 units of DNase I (Boehringer Mannheim) and
incubated at 22 °C for 45 min. The solubilized proteins extracted
from the Triton-insoluble pellet were obtained in the supernatant after
centrifugation.
Immunoprecipitation, Electrophoresis, Immunoblotting, and
Scanning Densitometry
Immunoprecipitations of the soluble
fractions were performed as described (13). For immunoprecipitation of
proteins in the Triton-insoluble fraction, solubilized proteins from
the Triton-insoluble fraction were obtained after treatment with DNase
I, equilibrated to 150 mM NaCl, and immunoprecipitated for
3 h at 4 °C. Samples were separated on two-dimensional
non-reducing/reducing SDS-PAGE and transferred onto nitrocellulose
filters as described (3, 4). For radiolabeled samples, filters were
exposed to x-ray films and later incubated with specific antibodies.
Proteins were detected with either anti-mouse immunoglobulin
horseradish peroxidase conjugate or protein A-horseradish peroxidase
conjugate. Biotinylated proteins were detected by adding
streptavidin-conjugated horseradish peroxidase. Visualization was
achieved using enhanced chemiluminescence (Amersham). Scanning
densitometry was done with the Bio-Rad Molecular Analyst System
(Hercules, CA) on multiple exposures to ensure linearity and accuracy
of the results.
RESULTS
Cska- Chain Forms a Complex with the CD3 , , and Subunits Which Is Expressed on the Cell Surface of Non-activated Normal
Lymphocytes
An important issue concerning the putative function
of cska- chain in non-activated lymphocytes is whether it assembles
with the TCR complex or is expressed on the cell surface independently
of the remainder of the TCR subunits. Thus, we first determined whether
any of the CD3 subunits could be detected in the detergent-insoluble
cytoskeletal fraction, together with the cska- chain. Accordingly,
we utilized a detergent-based lysis solution containing the
cytoskeleton-preserving buffer MES to minimize dissociation of loosely
bound cytoskeleton-associated molecules (Refs. 35 and 36; see also
``Experimental Procedures''). Upon lysis of freshly isolated
thymocytes, the TCR chain was detected in both the Triton-soluble
and Triton-insoluble fractions (Fig. 1A).
Increasing the lysis time or temperature from 4 to 22 °C (data not
shown) had no effect on the level of chain in each fraction;
30-40% of the chain was Triton-insoluble and 60-70% was
Triton-soluble. Analysis of CD3 subunit localization under similar
conditions revealed that there is a hierarchy for the association of
the TCR subunits with the cytoskeleton (Fig. 1A). While the
highest Triton-insoluble to Triton-soluble protein ratio (I/S ratio) is
maintained by the chain, the CD3 and chains can also be
detected in the Triton-insoluble cytoskeletal fraction. The CD3 chain also appears to be weakly associated with the cytoskeleton and
has the lowest I/S ratio. Similar results were also obtained following
the analysis of mouse splenocytes (data not shown).
Fig. 1.
A, differential localization of the TCR
invariant subunits to the detergent-insoluble cytoskeleton. Freshly
isolated thymocytes were lysed in the modified MES-lysis buffer (see
``Experimental Procedures''); Triton-soluble (SOL)
(2.5 × 107 cells) and Triton-insoluble
(INS) (5 × 107 cells) fractions were
denatured and separated by two-dimensional non-reducing/reducing
SDS-PAGE. After transfer to nitrocellulose filters, the filters were
incubated with polyclonal anti- , anti- , and anti-
antibodies and proteins were detected (see ``Experimental
Procedures''). To visualize the TCR subunits simultaneously,
autoradiograms were superimposed. B, the detergent-insoluble
CD3 subunits are associated with the cska- chain in normal
lymphocytes. Freshly isolated mouse thymocytes were cell surface
biotinylated (see ``Experimental Procedures''). Labeled cells were
lysed with MES-lysis buffer and Triton-soluble (SOL) and
insoluble (INS) fractions were obtained. These samples were
immunoprecipitated with anti- antibodies, separated by
two-dimensional non-reducing/reducing SDS-PAGE, and transferred to
nitrocellulose filters. Streptavidin-horseradish peroxidase and
enhanced chemiluminescence were used to detect biotinylated proteins on
the filters.
[View Larger Version of this Image (72K GIF file)]
We next analyzed whether cell surface-expressed cska- chain is
associated with the Triton-insoluble CD3 ( , , and ) subunits
and is part of the TCR complex. For this purpose, we performed
immunoprecipitations of the Triton-insoluble and Triton-soluble
fractions of freshly isolated thymocytes following cell-surface
labeling with biotin-ester (Fig. 1B). To retain potential
associations between non-covalently linked proteins in the
Triton-insoluble cytoskeletal fraction, we extracted the proteins in
the Triton-insoluble pellets with DNase I, and avoided the use of
denaturing agents. This enzyme digests the DNA in the nuclei which are
localized to the Triton-insoluble fraction and also induces in
vitro depolymerization of the actin microfilaments (37). Following
this procedure, anti- antibodies clearly immunoprecipitated not only
surface labeled chain, but also the CD3 , , and subunits
(Fig. 1B) as well as the Ti and chains (data not
shown). Although the relative level of Triton-insoluble chain is
greater than that of the CD3 subunits, when biotinylated, the latter
appear to have a greater representation in the Triton-insoluble
fraction. This discrepancy arises from the fact that the CD3 subunits
possess large extracellular domains with 4-9 lysine residues (targets
for biotinylation) as opposed to a single lysine residue in the short
extracellular domain of chain. Although we cannot rule out the
possibility that some of the cell surface-expressed cska- chain is
expressed independently of the TCR complex, the analysis of
immunoprecipitates derived using anti- (Fig. 1B) and
anti- (data not shown) antibodies clearly demonstrates that cska-
chain is physically associated with Triton-insoluble CD3 , , and
subunits. These results reveal that there are two TCR populations
expressed on the cell surface of non-activated T cells; one is linked
to the cytoskeleton while the other is detergent-soluble and not
associated with the cytoskeleton.
Localization of CD3 , , and Subunits to the
Triton-insoluble Fraction Is Enhanced Upon Their Association with
Cska-
To determine whether the localization of the CD3
subunits to the Triton-insoluble fraction depends upon the expression
of cska- chain, we examined the levels of Triton-insoluble CD3
chains in the 5.8 -deficient T cell hybridomas. Although 5.8 cells
do not express the chain, they synthesize the remaining TCR
subunits, most of which are degraded in the lysosome with a small
portion of -deficient TCR expressed on the cell surface (38).
Scanning densitometric analysis consistently showed that upon lysis of
5.8 cells, relatively low levels of the CD3 subunits were retained in
the Triton-insoluble fraction. The CD3 I/S ratio in 5.8 cells was
3-5-fold lower than that of the parental 2B4 hybridoma cells, which
express the chain and both the detergent-soluble and
cytoskeleton-linked TCR populations (Table I). To assess
whether the expression of chain affects the Triton-insolubility of
CD3, we transiently transfected 5.8 cells with full-length cDNA. Fluorescence-activated cell sorter analysis demonstrated that
following transfection, TCR cell-surface expression was reconstituted
(data not shown) and the transfectants displayed an I/S ratio for chain similar to that observed with the parental 2B4 cells (Table I).
Accordingly, we also found a 2-3-fold increase in the I/S ratio of CD3
and . Although the relative levels of Triton-insoluble and
in the transfected cells were increased, they did not reach those
of 2B4, likely due to the low transfection efficiency. In order to
determine whether the anchorage of CD3 to the cytoskeleton depends only
upon the expression of cska- , or whether it also requires correct
assembly with cska- , we also transfected 5.8 cells with a Tac
construct (see ``Experimental Procedures''). Tac is a chimeric
molecule which is expressed on the cell surface independently of the
rest of the TCR chains and does not ``drag'' them to the cell surface
(34). We demonstrate here that while surface-expressed Tac was
found both in the Triton-insoluble cytoskeletal fraction and the
Triton-soluble fraction, it did not reconstitute the levels of
Triton-insoluble CD3 (Table I) and was unable to invoke TCR cell
surface expression (data not shown). This is in contrast to what was
observed following transfections with full-length chain cDNA.
Consequently, the assembly of cska- chain with the CD3 subunits
appears necessary for optimal Triton-insoluble CD3 localization and the
CD3-cytoskeleton association appears to be mediated via the cska-
chain.
The Two TCR Populations in Non-activated T cells Possess Distinct
Forms of Chain
The results demonstrating that there are two
TCR populations, one of which is linked to the cytoskeleton via chain, raised the issue of whether the chains associated with each
population exhibit any differences. Our earlier studies (13) have
demonstrated that following cell surface iodination using
lactoperoxidase, cska- chain was preferentially labeled while only
trace levels of iodinated soluble chain were detected. It was
unclear at that time whether only the cska- chain resides on the
cell surface, or whether both forms are cell surface-expressed but
differentially iodinated due to specific structural differences. To
resolve this issue, we compared the labeling of the two forms by
using two different labeling methods, iodination and biotinylation.
While the former targets tyrosine residues, the latter binds to the
free amino groups, such as those on lysine residues. As shown in
Fig. 2, A-D, cell surface iodination of
freshly isolated thymocytes using lactoperoxidase labels cska- chain
(A) but does not yield detectable levels of labeled soluble
chain (A). However, cell surface labeling with
biotin-ester allows detection of both forms (C), albeit
with a preference for the cska- form. To verify that only cell
surface-expressed molecules are labeled by these two procedures, we
immunoprecipitated Lck, which is associated with the inner leaflet of
the membrane via a myristoyl group and, as such, represents an
exclusively cytosolic membrane-bound molecule. Since Lck could not be
detected following either iodination or biotinylation (data not shown),
it appears unlikely that intracellular molecules were labeled by these
procedures. Thus, both Triton-insoluble and soluble chains are
expressed on the cell surface, but differ in their ability to be
surface iodinated.
Fig. 2.
A-D, both soluble and cska- chains
are cell surface-labeled by biotinylation, but cska- is
preferentially labeled by iodination. Freshly isolated mouse thymocytes
were subjected to cell surface labeling by either iodination or
biotinylation (see ``Experimental Procedures''). Cells were lysed,
relegated to detergent-soluble (SOL), and insoluble
(INS) fractions and separated by two-dimensional
non-reducing/reducing SDS-PAGE. After transfer to nitrocellulose,
filters containing radiolabeled proteins were exposed to x-ray films
(A). Filters containing biotinylated proteins were treated
with streptavidin-horseradish peroxidase and subjected to enhanced
chemiluminescence (C). The filters containing labeled
proteins from the two labeling procedures were later incubated with
anti- antibodies and proteins were detected (B and
D) as described. E and F, in
non-activated thymocytes, the tyrosine-phosphorylated 21-kDa form
is exclusively localized to the detergent-soluble fraction while the
phosphorylated 16-kDa form is retained only in the
detergent-insoluble cytoskeletal fraction. Freshly isolated mouse
thymocytes were lysed with the MES lysis buffer. Detergent-soluble and
insoluble fractions were obtained and separated by two-dimensional
non-reducing/reducing SDS-PAGE and Western blotting was performed. The
nitrocellulose filters were incubated with either anti-
antibodies (E) or anti-phosphotyrosine antibodies
(F). Proteins were detected using either protein
A-horseradish peroxidase (E) or goat
anti-mouse-horseradish peroxidase (F) and enhanced
chemiluminescence.
[View Larger Version of this Image (43K GIF file)]
An additional difference between the two TCR populations which may well
have physiologic ramifications is the phosphorylation state of each of
the forms. Indeed, the possibility of such a dichotomous
phosphorylation pattern was raised in our previous study (13) which
demonstrated that one of the hallmarks of cska- chain is that a
certain level is constitutively phosphorylated in non-activated T
cells, yet despite this displays the same molecular mass as its soluble
non-phosphorylated 16-kDa counterpart. Various biochemical studies
analyzing the state of phosphorylation in freshly isolated young
lymphocytes have concentrated only on detergent-soluble fractions, and
have shown that in this fraction there is a basal level of 21-kDa
tyrosine-phosphorylated chain (9, 10). In order to assess whether
the 21-kDa form is also localized to the detergent-insoluble fraction,
we used thymocytes isolated from 4-week-old mice, which often have
basal levels of this form. The results shown in Fig. 2, E
and F, demonstrate that contrary to the phosphorylated
16-kDa form localized solely to the cytoskeletal fraction, the
21-kDa phosphorylated form was detected only in the detergent soluble
fraction. Similar results were obtained with freshly isolated
splenocytes (data not shown). Even after ``resting'' the lymphocytes
by incubation overnight at 37 °C, no 21-kDa phosphorylated could
be detected in the detergent-insoluble fraction despite the dramatic
decrease in the level of this form in the detergent-soluble fraction
(see Fig. 3A). Such differences observed in
non-activated T cells suggest putative distinct associations with
intracellular molecules even prior to activation, which in turn may
affect cellular functions upon antigen binding.
Fig. 3.
TCR-mediated stimulation of normal mouse
splenocytes induces activation-dependent modifications in
(A) and (B) TCR subunits. Mouse
splenocytes were activated with 2C11 ascites (1:250) for the indicated
times after resting overnight and lysed with MES lysis buffer. After
separation to Triton-soluble (SOL) and insoluble
(INS) fractions, samples (SOL, 5 × 107
cells; and INS, 1 × 108 cells) were subjected to
two-dimensional non-reducing/reducing SDS-PAGE (12-13%) and
transferred to nitrocellulose filters. Filters were incubated with
anti- antibodies (A), anti- antibodies (B),
or anti-phosphotyrosine antibodies (anti-pTyr, A and
B) followed by incubation with protein A-horseradish
peroxidase (for anti- and anti- ) or goat anti-mouse horseradish
peroxidase (for anti-phosphotyrosine). Protein detection was performed
as described. Open arrow indicates the position of the
soluble 21-kDa phosphorylated form, and filled arrow
indicates the position of the 16-kDa form in both fractions.
[View Larger Version of this Image (45K GIF file)]
Distinct Activation-dependent Modifications of the
Detergent-soluble and Cytoskeleton-associated TCR Populations
To
examine the putative function of the cytoskeleton-associated TCR
population, and its possible involvement in early receptor-mediated
signaling events, we studied the kinetics of
activation-dependent changes for each of the receptor
populations. For this purpose, we activated normal mouse splenocytes
for various time intervals with anti-CD3 antibodies cross-linked by
antigen presenting cells also derived from the splenic population. As
indicated in Fig. 3A, within 5 min of stimulation, there was
a dramatic increase in the level of 21-kDa phosphorylated chain,
indicative of TCR-mediated activation. However, even after 30 min of
stimulation, the 21-kDa phosphorylated form was localized
exclusively to the Triton-soluble fraction and was never observed in
association with the cytoskeleton. In contrast, the 16-kDa
phosphorylated form remained unique to the cytoskeletal fraction, even
after 30 min of stimulation (Fig. 3A). Moreover, the
phosphorylated 16-kDa cska- form was not enhanced upon TCR-mediated
activation, and in several experiments a slight
activation-dependent decrease was observed after 15-30 min
of activation. Despite little change in the level of 16-kDa
phosphorylated cska- form, the total protein level of cska-
(detected with anti- antibodies) showed an
activation-dependent increase which generally peaked
between 15 and 30 min (Fig. 3A). Under these conditions, a
slight decrease in Triton-soluble non-phosphorylated 16-kDa was
observed. Differences were also observed in the CD3 chains of the
two receptor populations. Despite an activation-induced increase in the
level of tyrosine phosphorylation of soluble chains and changes in
migration using two-dimensional non-reducing/reducing SDS-PAGE (Fig.
3B), only trace amounts of could be detected in the
detergent-insoluble cytoskeletal fraction both prior to and after
activation (data not shown). Even after 30 min of stimulation, no
phosphorylated or unphosphorylated could be detected in the
cytoskeletal fraction.
In the process of studying early activation-dependent
modifications of the two receptor populations, we analyzed the
ubiquitination state of soluble and cska- . Cenciarelli et
al. (39) have previously reported that TCR-triggering induces
ubiquitination of chain, but in this study only the Triton-soluble
fraction was analyzed. Therefore, we determined whether ubiquitinated
forms could also be detected in the Triton-insoluble cytoskeletal
fraction. In these experiments splenocytes were stimulated as described
above and the presence of chain in the various fractions was
analyzed. While the level of detergent-soluble ubiquitinated forms
reached a peak after about 30 min of stimulation, the level of
ubiquitinated cska- forms showed a dramatic increase which peaked
within 5 min of stimulation (Fig. 4A).
Moreover, both the 24-kDa ubiquitinated cska- and soluble forms
were phosphorylated (Fig. 4B), with peak phosphorylation
levels appearing within 5 min of activation for both forms. However,
the level of phosphorylation of the 24-kDa cska- form was
consistently higher than its soluble counterpart. Maintenance of the
dichotomy of phosphorylated soluble and cska- forms even after
activation, together with the differences in kinetics shown here,
suggest that each of the two TCR populations may play select roles in
receptor-mediated activation events.
Fig. 4.
Distinct activation-dependent
ubiquitination kinetics of the detergent-soluble and cska-
forms. Mouse splenocytes were treated and processed as described
in the legend to Fig. 3. Soluble (SOL) and insoluble
(INS) samples (5 × 107 cells each) were
subjected to two-dimensional non-reducing/reducing SDS-PAGE,
transferred to nitrocellulose filters, and incubated with anti-
antibodies (A) or anti-phosphotyrosine antibodies
(B). Proteins were detected as described. I,
indicates the position of the 24-kDa mono-ubiquitinated form.
II, indicates the position of the 32-kDa ubiquitinated form. III, indicates the position of the 40-kDa
ubiquitinated form.
[View Larger Version of this Image (50K GIF file)]
TCR-mediated Activation of Normal Splenocytes Induces Changes in
the Detergent-solubility of Lck
The
activation-dependent kinetics and differences observed in
the phosphorylation patterns of detergent soluble and cska- chains
strongly suggest that the cytoskeleton-associated TCR population may be
involved in early signaling events. Therefore, we determined whether
additional molecules which are known to play a role in early
TCR-mediated signaling events are also modified upon TCR triggering and
localize to the detergent-insoluble cytoskeletal fraction. In these
experiments, we performed a kinetic analysis to assess the
detergent-insoluble cytoskeletal localization of Lck upon T cell
activation. Our results show that in non-activated splenocytes, two
forms of Lck could be detected; the 56-kDa form present primarily in
the detergent-soluble fraction and a 60-kDa Lck form localized mainly
to the detergent-insoluble fraction. The two Lck forms were detected by
immunoblotting of total lysates (Fig. 5), or of
immunoprecipitated samples (data not shown). Subsequent to 1 min of TCR
triggering, the detergent-insoluble 60-kDa Lck form was no longer
detected and after 5 min of activation this 60-kDa form was also absent
in the detergent-soluble fraction (Fig. 5). However, after 30 min of
activation we observed a reappearance of the 60-kDa Lck form, in both
the detergent-soluble and detergent-insoluble cytoskeletal fractions.
While the 60-kDa Lck form is localized to both soluble and insoluble
fractions with specific activation-dependent kinetics, the
56-kDa Lck form localizes only to the detergent-soluble fraction
regardless of the state of activation. These results again demonstrate
that in our experimental system, there are molecules which are unique
to either the detergent-soluble or the detergent-insoluble cytoskeletal
fraction. Similar studies on Fyn and ZAP-70 protein tyrosine kinases
did not disclose significant levels of detergent-insoluble bands, at
least within the time frame utilized for Lck. Although the functional
significance of the two Lck forms is not yet understood, the transient
activation-dependent kinetics of Lck-cytoskeleton
association strengthen the claim that each of the two TCR populations
may initiate distinct cellular signaling cascades, and suggest that
additional signaling molecules may be involved in mediating these
functions.
Fig. 5.
Lck exhibits changes in
detergent-insolubility and apparent molecular weight following
TCR-mediated activation. Mouse splenocytes were activated with
2C11 ascites (1:250) for the indicated times after resting overnight,
and lysed with MES lysis buffer. Samples (2.5 × 107
cells) were separated to detergent-soluble (SOL) and
insoluble (INS) fractions, reduced, and subjected to 8%
SDS-PAGE. After transfer to nitrocellulose filters, detection of Lck
was achieved by incubation with polyclonal anti-Lck antibodies, protein
A-horseradish peroxidase, and enhanced chemiluminescence.
[View Larger Version of this Image (24K GIF file)]
DISCUSSION
In the current study we demonstrate that non-activated T cells
express two TCR forms on the cell surface. While one receptor form is
localized to the Triton-insoluble fraction and is associated with the
cytoskeleton via the chain, the other is Triton-soluble with no
anchorage to the cytoskeleton. Our study focuses on the differences
between these two receptor forms and on the inter-relation between the
CD3 subunits and the chain within the cytoskeleton-associated
receptors. In addition, we assess the potential physiologic
significance of these interactions in normal mouse lymphocytes, by
comparing the activation-dependent kinetics of
phosphorylation and ubiquitination of the Triton-soluble and
Triton-insoluble cska- forms.
Although previous studies described the localization of the TCR to
detergent-insoluble cytoskeletal fractions of cell lysates (40, 41),
little data was available pertaining to the nature of such
associations. Cumulative evidence suggests that the association of the
TCR chain with the cytoskeleton is mediated via the actin
microfilaments: 1) whereas interactions with microtubules are
temperature sensitive, the -cytoskeleton association is insensitive
to a range of temperatures.2 2) Our
previous results (13) describe the loss of Triton-insoluble chain
following treatment of cells with the actin microfilament
depolymerizing agent cytochalasin B; a recent study by Rozdzial
et al. (14) confirmed our results using cytochalasin D, and
also showed that chain and actin can be co-immunoprecipitated under
certain conditions. 3) As shown in the current study, DNase I, which is
also an actin depolymerizing agent (37), dissociates the TCR chain
from the Triton-insoluble pellet in vitro.
A crucial issue concerning the physiologic importance of cska- in
non-activated T cells is whether it associates with the TCR complex on
the cell surface or is independently expressed. Although the
cytoskeletal localization of the CD3 subunits (Fig. 1A)
hinted that cska- chain likely interacts with the TCR complex,
previous studies have shown that in T cells, the chain is not
necessarily limited to the TCR, but can exist as part of other receptor
complexes with different functions. For example, it was recently shown
that chain physically associates with the transferrin receptor and
undergoes phosphorylation upon activation via this receptor (42).
Moreover, it has been shown that the cell surface expressed TCR chain undergoes internalization and recycling independently of the
other TCR subunits (43). By co-immunoprecipitation analysis of the chain in the Triton-insoluble fraction, we provide strong evidence that
the cska- chain is associated with the rest of the TCR subunits
(Fig. 1B). These results indicate that there are two
cell-surface expressed TCR complexes: one is linked to the cytoskeleton
while the other is devoid of such an association.
Our analysis of -deficient 5.8 cells together with transfections
which reconstitute chain expression in these cells provides
compelling evidence that maximal CD3 detergent insolubility is likely
due to the bridging of CD3 to the cytoskeleton via chain. From this
analysis (Table I), it appears that the assembly of cska- with the
CD3 subunits is crucial for their detergent insolubility. Moreover,
since cska- chain links the CD3 subunits to the cytoskeleton and the
CD3 subunits display a hierarchy of localization to the
Triton-insoluble cytoskeletal fraction, it is possible that the degree
of CD3 cytoskeletal localization reflects the degree of their
interaction with the cska- chain. Several models have been suggested
depicting the interactions between the receptor subunits (44), but in
each case the chain was arbitrarily placed. Since the I/S ratio
follows the pattern: > >  , our data suggests that the
association between cska- and the CD3 subunits may be mediated
primarily via the and chains, in the cytoskeleton-linked
receptor population. However, a fuller understanding of the complex
interactions between the various receptor subunits awaits a more
detailed study. These results suggest that the cska- chain is the
main distinguishing feature between these two receptor populations.
It is not known whether there are differences between the two TCR forms which might account for their differential interactions with the
cytoskeleton or alternatively, result from such interactions. A
difference in the amino acid sequence of the two forms was excluded
since chain is localized to both Triton-soluble and
Triton-insoluble fractions following transfection of wild type cDNA to -deficient cells. In addition, several monoclonal and
polyclonal antibodies directed at different epitopes recognize both forms. Another possibility is that cska- chain appears in a
different conformation than the soluble chain. Indeed, our studies
utilizing two different labeling techniques (Fig. 2, A-D)
revealed that following biotinylation both cska- and soluble chains are expressed on the cell surface, but are differentially
labeled by iodination. These results suggest that either a difference
in chain conformation or occlusion of the tyrosine residue due to
steric interference by neighboring subunits could result in poor
iodination of the detergent-soluble chain. Alternatively,
association with the cytoskeleton could lead to enhanced exposure of
the only tyrosine residue localized to the interface between the
transmembrane and extracellular domains. An example of such changes in
receptor conformation induced by association with the cytoskeleton
comes from a recent report by Gronowski and Bertics (17). Their study
shows that a cytoskeleton-associated epidermal growth factor receptor
population binds its ligand with a greater affinity than the soluble
receptor counterparts, suggesting that this enhanced affinity could
result from changes in receptor conformation.
A clue to the putative differential function of the two forms in
non-activated lymphocytes can be derived from our observations
demonstrating their differential state of phosphorylation (Fig. 2,
E and F). Despite being phosphorylated in
non-activated T cells, the cska- chain maintains an apparent
molecular mass of 16 kDa, while its soluble 16-kDa counterpart is
non-phosphorylated. Furthermore, the soluble fraction of freshly
isolated thymocytes and splenocytes often contains a 21-kDa
phosphorylated form (typical of activated T cells and indicative of
basal activation in vivo) which is not observed in the
Triton-insoluble cytoskeletal fraction. The dissimilarity in the
apparent molecular masses of the two phosphorylated forms could
result from variations in the number of phosphorylated tyrosine
residues and/or from differences in the site of phosphorylation. The
unique phosphorylated cska- form could mediate signaling pathways
different from those mediated by the 21-kDa soluble phosphorylated form.
Much effort has been made to elucidate the function of
receptor-cytoskeleton associations (reviewed in Ref. 15). In this
study, we provide evidence that the two receptor populations may well
mediate different intracellular signaling cascades leading to distinct
cellular effects. We have shown that the
activation-dependent ubiquitination of chain, which was
previously reported by Cenciarelli et al. (39), is common to
both TCR populations. However, there are definite differences in the
kinetics of this modification (Fig. 4A). The functional
significance of these differential kinetics may be difficult to assess;
a recent study by Hou et al. (45) did not observe any
changes in the half-life of chain in cells stably transfected with
a mutated chain which is unable to undergo ubiquitination. However,
the role of the differential kinetics of ubiquitination in the soluble
and cytoskeletal fractions awaits a systematic study in normal
lymphocytes.
One of our more intriguing observations is that the two major
phosphorylated forms, the 21-kDa soluble form and 16-kDa cska-
form, each remain in their respective fractions even following 30 min
(Fig. 3) and 50 min (data not shown) of stimulation. This dichotomy is
maintained despite various activation-dependent modifications,
including enhancement of the soluble 21-kDa phosphorylated form. The
mode of phosphorylation of each of these forms could be of major
importance in determining their function. For example, while ZAP-70 has
been shown to utilize its tandem SH2 domains in a cooperative
interaction to bind to paired phosphorylated tyrosine residues in the
intracellular region of chain (46), Fyn has been shown to bind to
the first -immune receptor tyrosine-based activation motif when it
contains a single phosphorylated tyrosine residue (47). Since the
Triton-soluble phosphorylated 21-kDa chain apparently differs in
its phosphorylation pattern from that of the cska- chain, there
could be important differences between the two forms in the binding
to ZAP-70, Fyn, and other intracellular signaling molecules.
A recent report by Rozdzial et al. (14) is in agreement with
our earlier findings showing that resting lymphocytes contain levels of
cska- . Moreover, both their study and our current work show that
there is an activation-dependent translocation of chain
to the cytoskeleton. However, our study clearly shows that while the
level of phosphorylated soluble 21-kDa chain increases after 5-30
min of stimulation, no parallel increase is observed in the level of
16-kDa phosphorylated cska- form. This contrasts with the above
mentioned study (14) which claims that the level of phosphorylation of
cska- is greatly enhanced upon activation. How can these results be
reconciled? One possibility is that the stimulation of T cell
hybridomas transfected with -chimeric molecules induces a different
phosphorylation pattern from the one we observed using normal mouse
splenocytes. Another possibility relates to the type of analysis
utilized: by non-reducing/reducing two-dimensional SDS-PAGE, we were
able to differentiate between the various forms, including the
soluble 21-kDa phosphorylated form, the 16-kDa phosphorylated cska-
form, and the phosphorylated ubiquitinated forms. Since analysis in
non-reducing one-dimensional SDS-PAGE is less informative, the authors
(14) may have observed the sum total of all the insoluble
phosphorylated forms: the 16-kDa form which does not increase, and the
24-kDa phosphorylated ubiquitinated form which we find is enhanced upon
TCR-stimulation (Fig. 4B), particularly in the cytoskeletal
fraction (Fig. 4B).
Our results, which provide information regarding the kinetics and mode
of phosphorylation of cska- , suggest a unique function for this form
in TCR-mediated activation, possibly by differential interactions with
various intracellular signaling molecules. It is possible that the
cytoskeleton serves as a matrix for the recruitment and concentration
of signaling molecules, which facilitates molecular communications.
Indeed, recent studies on platelets (reviewed in Ref. 48) show that
various kinases, including those of the src family, are translocated to
the cytoskeleton after cell activation. Moreover, a recent study in T
cells depicts the translocation of ZAP-70 as well as the Grb2 and
PLC 1 molecules to a detergent-insoluble spectrin-enriched fraction
subsequent to TCR-mediated activation (49). In our study, we
demonstrate that Lck, a key src-family kinase involved in TCR-mediated
signaling, also undergoes activation-dependent
translocation to the cytoskeleton and a shift in its apparent molecular
weight. Ascertaining whether detergent-insoluble Lck binds to cska-
remains a priority for future studies, but may necessitate the use of
sophisticated cross-linking analysis. Although the role of
kinase-cytoskeletal localization is not yet clear, evidence points to
significant differences in kinase activity for enzymes linked to the
cytoskeleton. For example, it was recently demonstrated that upon
receptor ligation, the kinase activity of the cytoskeleton-associated
epidermal growth factor receptors is greater than that of the soluble
receptors (50). Although no evidence is yet available concerning the
putative function of the 60-kDa detergent-insoluble Lck form (present
in non-activated and activated T cells), there is a possibility that
this form may also possess enhanced kinase activity and play a role in
the phosphorylation of cska- .
What is the role of cska- and the cytoskeleton-linked TCR? From our
results, it is tempting to speculate that the cytoskeleton-linked
receptor population could mediate distinct intracellular signaling
cascades. If the actin-based microfilament system is required for
TCR-mediated activation as suggested (51, 52), then it is possible that
the 16-kDa phosphorylated cska- form could perhaps maintain the
cells in a state of partial activation where they can respond swiftly
to stimulation, either by their ability to sequester
phosphorylation-dependent associated kinases, or by
undergoing additional phosphorylation and translocation to the soluble
fraction as a 21-kDa phosphorylated form. However, a study by
DeBell et al. (53) suggests that the cytoskeleton could play
a role in curbing TCR-mediated signaling events. The 16-kDa
phosphorylated cska- form and its associated TCR subunits might
negatively regulate TCR-mediated signaling as observed in anergy.
Recent studies (54, 55) discuss the potential significance of the 18- and 21-kDa phosphorylated forms in the detergent-soluble fraction,
and the possibility that the ratio of these forms plays a role in
binding different kinases and determining whether receptor ligation
ultimately culminates in activation or anergy. Although the role of
cska- and its putative relation to anergy was beyond the scope of
this work, such studies may eventually shed light on the function of
the phosphorylated 16-kDa cska- form. Additional studies will be
required to discern the roles of the various phosphorylated forms
associated with the two TCR populations in igniting or braking the
molecular machinery involved in TCR-mediated signal transduction.
FOOTNOTES
*
This work was supported by the Concern Foundation of Los
Angeles and by the United States-Israel Binational Science Foundation.
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: The Lautenberg Center
for General and Tumor Immunology, Hebrew University-Hadassah Medical
School, Jerusalem 91120, Israel. Tel.: 972-2-757461; Fax:
972-2-424653.
1
The abbreviations used are: TCR, T cell
antigen receptor; PAGE, polyacrylamide gel electrophoresis; MES,
4-morpholineethanesulfonic acid.
2
S. Caplan and M. Baniyash, unpublished
data.
Acknowledgments
We thank Larry Samelson, Stu Frank, and
Francois Letourneur for their generous provision of the FL and
T cDNA constructs. We are especially grateful to Avery Ben
Zeev for his expertise. We also thank Benjamin Rivnay, Aubrey Caplan,
Eitan Yefenof, and Larry Samelson for the critical reading of this
manuscript. We gratefully acknowledge the support of the Society for
Research Associates of the Lautenberg Center.
REFERENCES
-
Weiss, A.,
Littman, D.
(1994)
Cell
76,
263-274
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rudd, C. E.,
Janssen, O.,
Yun-Cai, C.,
da Silva, A. J.,
Raab, M.,
Prasad, K. V. S.
(1994)
Immunol. Today
15,
225-234
[CrossRef][Medline]
[Order article via Infotrieve]
-
Samelson, L. E.,
Patel, M. D.,
Weissman, A. M.,
Harford, J. B.,
Klausner, R. D.
(1986)
Cell
46,
1083-1090
[CrossRef][Medline]
[Order article via Infotrieve]
-
Baniyash, M.,
Garcia-Morales, P.,
Luong, E.,
Samelson, L. E.,
Klausner, R. D.
(1988)
J. Biol. Chem.
263,
18225-18230
[Abstract/Free Full Text]
-
Samelson, L. E.,
Klausner, R. D.
(1992)
J. Biol. Chem.
267,
24913-24916
[Free Full Text]
-
Weiss, A.
(1993)
Cell
73,
209-212
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sarosi, G. A.,
Thomas, P. M.,
Egerton, M.,
Phillips, A. F.,
Kim, K. W.,
Bonvini, E.,
Samelson, L. E.
(1992)
Int. Immunol.
4,
1211-1217
[Abstract/Free Full Text]
-
Timson Gauen, L. K.,
Kong, A. N. T.,
Samelson, L. E.,
Shaw, A. S.
(1992)
Mol. Cell. Biol.
12,
5438-5446
[Abstract/Free Full Text]
-
Nakayama, T.,
Singer, A.,
Hsi, E. D.,
Samelson, L. E.
(1989)
Nature
341,
651-654
[CrossRef][Medline]
[Order article via Infotrieve]
-
van Oers, N. S. C.,
Killeen, N.,
Weiss, A.
(1994)
Immunity
1,
675-685
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ravichandran, K. S.,
Lee, K. K.,
Songyang, Z.,
Cantley, L. C.,
Burn, P.,
Burakoff, S. J.
(1993)
Science
262,
902-904
[Abstract/Free Full Text]
-
Osman, N.,
Lucas, S. C.,
Turner, H.,
Cantrell, D.
(1995)
J. Biol. Chem.
270,
13981-13986
[Abstract/Free Full Text]
-
Caplan, S.,
Zeliger, S.,
Wang, L.,
Baniyash, M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4768-4772
[Abstract/Free Full Text]
-
Rozdzial, M. M.,
Malissen, B.,
Finkel, T. H.
(1995)
Immunity
3,
823-833
[CrossRef]
-
Caplan, S.,
Baniyash, M.
(1995)
Immunol. Res.
14,
98-118
[Medline]
[Order article via Infotrieve]
-
den Hartigh, J. C.,
van Bergen,
Henegouwen, P. M. P.,
Verkleij, A.
J.,
Boonstra, J.
(1992)
J. Cell Biol.
119,
349-355
[Abstract/Free Full Text]
-
Gronowski, A. M.,
Bertics, P. J.
(1993)
Endocrinology
133,
2838-2846
[Abstract/Free Full Text]
-
Luna, E. J.,
Hitt, A. L.
(1992)
Science
258,
955-963
[Abstract/Free Full Text]
-
Offringa, R.,
Bierer, B. E.
(1993)
J. Biol. Chem.
268,
4979-4988
[Abstract/Free Full Text]
-
Lokeshwar, V. B.,
Bourguignon, L. Y. W.
(1992)
J. Biol. Chem.
287,
21551-21557
-
Braun, J.,
Hochman, P. S.,
Unanue, E. R.
(1982)
J. Immunol.
128,
1198-1204
[Abstract]
-
Woda, B. A.,
McFadden, M. L.
(1983)
J. Immunol.
131,
1917-1919
[Abstract]
-
Woda, B. A.,
Woodin, M. B.
(1984)
J. Immunol.
133,
2767-2772
[Abstract]
-
Albrecht, D. L.,
Noelle, R. J.
(1988)
J. Immunol.
141,
3915-3922
[Abstract]
-
Robertson, D.,
Holowka, D.,
Baird, B.
(1986)
J. Immunol.
136,
4565-4572
[Abstract]
-
Apgar, J. R.
(1990)
J. Immunol.
145,
3814-3822
[Abstract]
-
Mao, S. Y.,
Alber, G.,
Rivera, J.,
Kochan, J.,
Metzger, H.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
222-226
[Abstract/Free Full Text]
-
Hedrick, S. M.,
Matis, L. A.,
Hecht, T. T.,
Samelson, L. E.,
Longo, D.
L.,
Heber-Katz, E.,
Schwartz, R. H.
(1982)
Cell
30,
141-152
[CrossRef][Medline]
[Order article via Infotrieve]
-
Leo, O.,
Foor, M.,
Sachs, D. M.,
Samelson, L. E.,
Bluestone, J. A.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1374-1378
[Abstract/Free Full Text]
-
Samelson, L. E.,
Weissman, A. M.,
Robey, F. A.,
Berkower, I.,
Klausner
(1986)
J. Immunol.
137,
3254-3258
[Abstract]
-
Orloff, D. G.,
Frank, S. J.,
Robey, F. A.,
Weissman, A. M.,
Klausner, R. D.
(1989)
J. Biol. Chem.
264,
14812-14817
[Abstract/Free Full Text]
-
Frank, S. J.,
Niklinska, B. B.,
Orloff, D. G.,
Mercep, M.,
Ashwell, J.
D.,
Klausner, R. D.
(1990)
Science
249,
174-177
[Abstract/Free Full Text]
-
Takebe, Y.,
Seiki, M.,
Fujisawa, J.,
Hoy, P.,
Yokota, K.,
Arai, K.,
Yoshida, M.,
Arai, N.
(1988)
Mol. Cell. Biol.
8,
466-472
[Abstract/Free Full Text]
-
Letourneur, F.,
Klausner, R. D.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
8905-8909
[Abstract/Free Full Text]
-
Avnur, Z.,
Small, J. V.,
Geiger, B.
(1983)
J. Cell Biol.
96,
1622-1630
[Abstract/Free Full Text]
-
Hamel, E.,
Lin, C. N.
(1984)
Biochemistry
23,
4173-4184
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lelkes, P. I.,
Friedman, J. E.,
Rosenheck, K.,
Oplatka, A.
(1986)
FEBS Lett.
208,
357-363
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sussman, J. J.,
Bonifacino, J. S.,
Lippincott-Schwartz, J.,
Weissman, A. M.,
Saito, T.,
Klausner, R. D.,
Ashwell, J. D.
(1988)
Cell
52,
85-95
[CrossRef][Medline]
[Order article via Infotrieve]
-
Cenciarelli, C.,
Hou, D.,
Hsu, K.-C.,
Rellahan, B. L.,
Wiest, D. L.,
Smith, H. T.,
Fried, V. A.,
Weissman, A. M.
(1992)
Science
257,
795-7978
[Abstract/Free Full Text]
-
Marano, N.,
Holowka, D.,
Baird, B.
(1989)
J. Immunol.
143,
931-938
[Abstract]
-
Geppert, T. D.,
Lipsky, P. E.
(1991)
J. Immunol.
146,
3298-3305
[Abstract]
-
Salmerón, A.,
Borroto, A.,
Fresno, M.,
Crumpton, M. J.,
Ley, S.
C.,
Alarcón, B.
(1995)
J. Immunol.
154,
1675-1683
[Abstract]
-
Ono, S.,
Ohno, H.,
Saito, T.
(1995)
Immunity
2,
639-644
[CrossRef][Medline]
[Order article via Infotrieve]
-
Manolios, N.,
Kemp, O.,
Li, Z. G.
(1994)
Eur. J. Immunol.
24,
84-92
[Medline]
[Order article via Infotrieve]
-
Hou, D.,
Cenciarelli, C.,
Jensen, J. P.,
Nguyen, H. B.,
Weissman, A. M.
(1994)
J. Biol. Chem.
269,
14244-14247
[Abstract/Free Full Text]
-
Isakov, N.,
Wange, R. L.,
Burgess, W. H.,
Watts, J. D.,
Aebersold, R.,
Samelson, L. E.
(1995)
J. Exp. Med.
181,
375-380
[Abstract/Free Full Text]
-
Osman, N.,
Lucas, S.,
Cantrell, D.
(1995)
Eur. J. Immunol.
25,
2863-2869
[Medline]
[Order article via Infotrieve]
-
Clark, E. A.,
Shattil, S. J.,
Brugge, J. S.
(1994)
Trends Biochem. Sci.
19,
464-469
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nel, A. E.,
Gupta, S.,
Lee, L.,
Ledbetter, J. A.,
Kanner, S. B.
(1995)
J. Biol. Chem.
270,
18428-18436
[Abstract/Free Full Text]
-
Gronowski, A. M.,
Bertics, P. J.
(1995)
Endocrinology
136,
2198-2205
[Abstract]
-
Parsey, M. V.,
Lewis, G. K.
(1993)
J. Immunol.
151,
1881-1893
[Abstract]
-
Valitutti, S.,
Dessing, M.,
Aktories, K.,
Gallati, H.,
Lanzavecchia, A.
(1995)
J. Exp. Med.
181,
577-584
[Abstract/Free Full Text]
-
DeBell, K. E.,
Conti, A.,
Alava, M. A.,
Hoffman, T.,
Bonvini, E.
(1992)
J. Immunol.
149,
2271-2280
[Abstract]
-
Sloan-Lancaster, J.,
Shaw, A. S.,
Rothbard, J. B.,
Allen, P. M.
(1994)
Cell
79,
913-922
[CrossRef][Medline]
[Order article via Infotrieve]
-
Madrenas, J.,
Wange, R. L.,
Wang, J. L.,
Isakov, N.,
Samelson, L. E.,
Germain, R. N.
(1995)
Science
267,
515-518
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Varma
TCR Triggering by the pMHC Complex: Valency, Affinity, and Dynamics
Sci. Signal.,
May 13, 2008;
1(19):
pe21 - pe21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Lysechko and H. L. Ostergaard
Differential Src Family Kinase Activity Requirements for CD3{zeta} Phosphorylation/ZAP70 Recruitment and CD3{epsilon} Phosphorylation
J. Immunol.,
June 15, 2005;
174(12):
7807 - 7814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A Lyubchenko, G. A Wurth, and A. Zweifach
The actin cytoskeleton and cytotoxic T lymphocytes: evidence for multiple roles that could affect granule exocytosis-dependent target cell killing
J. Physiol.,
March 15, 2003;
547(3):
835 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Garcia and R. A. Miller
Age-Dependent Defects in TCR-Triggered Cytoskeletal Rearrangement in CD4+ T Cells
J. Immunol.,
November 1, 2002;
169(9):
5021 - 5027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Krishnan, V. G. Warke, M. P. Nambiar, H. K. Wong, G. C. Tsokos, and D. L. Farber
Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3{zeta} expression
Blood,
June 15, 2001;
97(12):
3851 - 3859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Krawczyk and J. M. Penninger
Molecular motors involved in T cell receptor clusterings
J. Leukoc. Biol.,
March 1, 2001;
69(3):
317 - 330.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Arrieumerlou, C. Randriamampita, G. Bismuth, and A. Trautmann
Rac Is Involved in Early TCR Signaling
J. Immunol.,
September 15, 2000;
165(6):
3182 - 3189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bronstein-Sitton, L. Wang, L. Cohen, and M. Baniyash
Expression of the T Cell Antigen Receptor zeta Chain following Activation Is Controlled at Distinct Checkpoints. IMPLICATIONS FOR CELL SURFACE RECEPTOR DOWN-MODULATION AND RE-EXPRESSION
J. Biol. Chem.,
August 13, 1999;
274(33):
23659 - 23665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Annenkov, S. P. Moyes, Z. Eshhar, R. A. Mageed, and Y. Chernajovsky
Loss of Original Antigenic Specificity in T Cell Hybridomas Transduced with a Chimeric Receptor Containing Single-Chain Fv of an Anti-Collagen Antibody and Fc{epsilon}RI-Signaling {gamma} Subunit
J. Immunol.,
December 15, 1998;
161(12):
6604 - 6613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Rozdzial, C. M. Pleiman, J. C. Cambier, and T. H. Finkel3
pp56Lck Mediates TCR {zeta}-Chain Binding to the Microfilament Cytoskeleton
J. Immunol.,
November 15, 1998;
161(10):
5491 - 5499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Woodside, D. K. Wooten, and B. W. McIntyre
Adenosine Diphosphate (ADP)-Ribosylation of the Guanosine Triphosphatase (GTPase) Rho in Resting Peripheral Blood Human T Lymphocytes Results in Pseudopodial Extension and the Inhibition of T Cell Activation
J. Exp. Med.,
October 5, 1998;
188(7):
1211 - 1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. N. Berg, L. G. Puente, W. Dawicki, and H. L. Ostergaard
Sustained TCR Signaling Is Required for Mitogen-Activated Protein Kinase Activation and Degranulation by Cytotoxic T Lymphocytes
J. Immunol.,
September 15, 1998;
161(6):
2919 - 2924.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|